Kirkland Advises Bristol-Myers Squibb on iPierian Buy

, The Am Law Daily

   | 0 Comments

Bristol-Myers Squibb is paying up to $725 million for biotech firm iPierian.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202653226824

Thank you!

This article's comments will be reviewed.